With more than 25 years of experience, William Hagstrom stands as a leader in the healthcare industry.

He is currently the chief executive officer of Crescendo Bioscience, a molecular diagnostics laboratory headquartered in South San Francisco, CA. Focusing its chief research on rheumatoid arthritis, Crescendo Bioscience aims to "develop objective molecular tests to provide rheumatologists with deeper clinical insights into biology, to help enable more effective management of patients with autoimmune and inflammatory diseases," according to the company's Web site. Its researchers presented three studies reporting on the "successive refinement of statistical models to associate candidate serum protein biomarkers with the severity of RA disease activity" at the 73rd annual meeting of the American College of Rheumatology in October 2009. By demonstrating "superior predictive value of a multi-protein biomarker index as compared to any single measure," the research, as reported on ...

Click here to continuously play all of the videos from this speaker in a new window.

Description

From his first experiences as an entrepreneur, William Hagstrom, CEO of Crescendo Bioscience, relates the importance of strategy and its integration into the business model. Added to this vision, he believes a CEO of a healthcare firm must have a thorough knowledge and understanding of the technical and scientific aspects pertaining to the business. Because there is little margin for error, the company leader must also be a multitasking dynamo with sound judgment who can deliver results. In short, the CEO must do more than talk, he must act.